ライフサイエンスコーパス: craniospinal irradiation

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 iospinal irradiation (<30 Gy or >30 Gy vs no craniospinal irradiation).

2 consequence of chemotherapy or prophylactic craniospinal irradiation.

3 ed after 12 cycles of chemotherapy and local craniospinal irradiation.

4 ous peripheral blood stem-cell rescue before craniospinal irradiation.

5 Two of 3 received craniospinal irradiation (2,560/3,840 cGy) and (3,520/5,

6 Ninety-seven patients received craniospinal irradiation (23.4 Gy) followed by 55.8 Gy t

7 Craniospinal irradiation (24 Gy cranial/15 Gy spinal) wa

8 hosphamide (one to three cycles) followed by craniospinal irradiation (25.2 to 36 Gy) and a boost to

9 Craniospinal irradiation and chemotherapy were negativel

10 aged 3-16 years in patients (n=215) who had craniospinal irradiation and had been treated with a cur

11 Fourteen patients were treated with craniospinal irradiation, and 11 were treated with local

12 NS relapse, treatment that delays definitive craniospinal irradiation by 6 months to allow for more i

13 To compare quality of survival after craniospinal irradiation (CSI) alone with survival after

14 l study examined the effects of risk-adapted craniospinal irradiation (CSI) dose and the interactions

15 (RT) in 57 (30%), local RT in 87 (45%), and craniospinal irradiation (CSI) in 49 (25%).

16 ed the effect of treatment with reduced-dose craniospinal irradiation (CSI) plus a tumor bed boost ve

17 I trial of temozolomide stratified by prior craniospinal irradiation (CSI).

18 The median craniospinal irradiation dose was 23.4 GyRBE (IQR 23.4-2

19 patients consisted of surgical resection and craniospinal irradiation, followed by the same chemother

20 em-cell support after surgical resection and craniospinal irradiation is feasible in newly diagnosed

21 t of chemotherapy (yes vs no) and receipt of craniospinal irradiation (<30 Gy or >30 Gy vs no cranios

22 were treated with postsurgical risk-adapted craniospinal irradiation (n = 36 high risk [HR]; n = 90

23 Patients had craniospinal irradiation of 18-36 Gy radiobiological equ

24 y with or without second-look surgery before craniospinal irradiation on response rates and survival

25 ry 4 weeks, after completion of risk-adapted craniospinal irradiation to children with newly diagnose

26 treatment groups (no CRT, focal irradiation, craniospinal irradiation) using the chi(2) test.

27 In multivariable models, craniospinal irradiation was associated with a 1.5- to t

28 matter (NWM) related to their treatment with craniospinal irradiation with or without chemotherapy, a

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。